Haptoglobin Acts as a TLR4 Ligand to Suppress Osteoclastogenesis via the TLR4-IFN-β Axis

J Immunol. 2019 Jun 15;202(12):3359-3369. doi: 10.4049/jimmunol.1800661. Epub 2019 May 10.

Abstract

Haptoglobin (Hp), a type of acute-phase protein, is known to have a systemic anti-inflammatory function and to modulate inflammation by directly affecting immune cells, such as T cells, dendritic cells, and macrophages. However, the effects of Hp on osteoclast differentiation are not well studied, even though osteoclast precursor cells belong to a macrophage-monocyte lineage. In this study, we found that the bone volume was reduced, and the number of osteoclasts was increased in Hp-deficient mice compared with wild-type mice. Moreover, our in vitro studies showed that Hp inhibits osteoclastogenesis by reducing the protein level of c-Fos at the early phase of osteoclast differentiation. We revealed that Hp-induced suppression of c-Fos was mediated by increased IFN-β levels. Furthermore, Hp stimulated IFN-β via a TLR4-dependent mechanism. These results demonstrate that Hp plays a protective role against excessive osteoclastogenesis via the Hp-TLR4-IFN-β axis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Reaction
  • Animals
  • Bone Resorption / genetics
  • Cell Differentiation
  • Cells, Cultured
  • Haptoglobins / genetics
  • Haptoglobins / metabolism*
  • Interferon-beta / metabolism*
  • Ligands
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Osteoclasts / physiology*
  • Osteogenesis
  • Proto-Oncogene Proteins c-fos / genetics
  • Proto-Oncogene Proteins c-fos / metabolism
  • Signal Transduction

Substances

  • Haptoglobins
  • Ligands
  • Proto-Oncogene Proteins c-fos
  • Interferon-beta